Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression.

Bendall ML, de Mulder M, Iñiguez LP, Lecanda-Sánchez A, Pérez-Losada M, Ostrowski MA, Jones RB, Mulder LCF, Reyes-Terán G, Crandall KA, Ormsby CE, Nixon DF.

PLoS Comput Biol. 2019 Sep 30;15(9):e1006453. doi: 10.1371/journal.pcbi.1006453. eCollection 2019 Sep.

2.

High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome.

Oemrawsingh RM, Akkerhuis KM, de Mulder M, Umans VA, Kietselaer B, Schotborgh C, Ronner E, Lenderink T, Liem A, Haitsma D, van der Harst P, Asselbergs FW, Maas A, Oude Ophuis AJ, Ilmer B, Dijkgraaf R, de Winter RJ, Kie The SH, Wardeh AJ, Hermans W, Cramer E, van Schaik RH, Hoefer IE, Doevendans PA, Simoons ML, Boersma E; BIOMArCS Investigators.

Circulation. 2019 Jan 2;139(1):134-136. doi: 10.1161/CIRCULATIONAHA.118.036349. No abstract available.

PMID:
30592652
3.

Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.

de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF, Michaud HA.

Retrovirology. 2017 Aug 22;14(1):41. doi: 10.1186/s12977-017-0365-2.

4.

Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome.

van den Berg VJ, Umans VA, Stam F, de Mulder M, Akkerhuis KM, Cornel JH, Kardys I, Boersma E.

Circulation. 2016 Sep 27;134(13):984-6. doi: 10.1161/CIRCULATIONAHA.116.023480. No abstract available.

PMID:
27672199
5.

A curly case: dissecting giant arteriovenous anomaly - left main coronary artery shunting to superior vena cava.

de Mulder M, Hendriksz TR, de Jong PL, IJsselmuiden AJ.

EuroIntervention. 2015 Oct;11(6):e1. doi: 10.4244/EIJV11I6A132. No abstract available.

6.

Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses.

Rojas Sánchez P, de Mulder M, Fernandez-Cooke E, Prieto L, Rojo P, Jiménez de Ory S, José Mellado M, Navarro M, Tomas Ramos J, Holguín Á; Madrid Cohort of HIV-Infected Children and Adolescents Integrated in the Paediatric Branch of the Spanish National AIDS Network (CoRISPe).

Clin Microbiol Infect. 2015 Jun;21(6):605.e1-9. doi: 10.1016/j.cmi.2015.02.003. Epub 2015 Feb 11.

7.

Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells.

Michaud HA, SenGupta D, de Mulder M, Deeks SG, Martin JN, Kobie JJ, Sacha JB, Nixon DF.

J Immunol. 2014 Aug 15;193(4):1544-8. doi: 10.4049/jimmunol.1302108. Epub 2014 Jul 14.

8.

Intensive glucose control for acute myocardial infarction--reply.

de Mulder M, Umans VA, Boersma E.

JAMA Intern Med. 2014 May;174(5):826-7. doi: 10.1001/jamainternmed.2014.343. No abstract available.

PMID:
24799015
9.

Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.

Michaud HA, de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF.

Retrovirology. 2014 Jan 28;11:10. doi: 10.1186/1742-4690-11-10.

10.

HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA.

de Mulder M, York VA, Wiznia AA, Michaud HA, Nixon DF, Holguin A, Rosenberg MG.

HIV Med. 2014 Mar;15(3):135-43. doi: 10.1111/hiv.12089. Epub 2013 Sep 25.

11.

Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial.

de Mulder M, Umans VA, Cornel JH, van der Zant FM, Stam F, Oemrawsingh RM, Akkerhuis KM, Boersma E.

JAMA Intern Med. 2013 Nov 11;173(20):1896-904. doi: 10.1001/jamainternmed.2013.10074.

PMID:
24018647
12.

Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain.

Yebra G, de Mulder M, Holguín Á.

PLoS One. 2013 May 22;8(5):e64293. doi: 10.1371/journal.pone.0064293. Print 2013.

13.

High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.

de Mulder M, Yebra G, Navas A, de José MI, Gurbindo MD, González-Tomé MI, Mellado MJ, Saavedra-Lozano J, Muñoz-Fernández MÁ, de Ory SJ, Ramos JT, Holguín A; Madrid Cohort of HIV-Infected Children.

PLoS One. 2012;7(12):e52155. doi: 10.1371/journal.pone.0052155. Epub 2012 Dec 17.

14.

High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.

Briz V, García D, Méndez-Lagares G, Ruiz-Mateos E, de Mulder M, Moreno-Pérez D, Navarro ML, León-Leal JA, de José MI, Ramos JT, Mellado MJ, González-Tomé MI, Leal M, Muñoz-Fernández MA.

Pediatr Infect Dis J. 2012 Oct;31(10):1048-52.

PMID:
22828644
15.

Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.

de Mulder M, Yebra G, Navas A, Martin L, de Jose MI, Navarro ML, de Ory SJ, Gonzalez-Granado I, Mellado MJ, Ramos JT, Holguin A.

Pediatr Infect Dis J. 2012 Nov;31(11):e213-21. doi: 10.1097/INF.0b013e3182678c7c.

PMID:
22785049
16.

[Dried blood spots for monitoring HIV infection in Public Health Programs in developing countries].

De Mulder M, Holguín A.

Enferm Infecc Microbiol Clin. 2013 Feb;31(2):100-7. doi: 10.1016/j.eimc.2012.03.008. Epub 2012 May 4. Review. Spanish.

PMID:
22560588
17.

Admission glucose does not improve GRACE score at 6 months and 5 years after myocardial infarction.

de Mulder M, van der Ploeg T, de Waard GA, Boersma E, Umans VA.

Cardiology. 2011;120(4):227-34. doi: 10.1159/000335715. Epub 2012 Feb 15.

PMID:
22343543
18.

Long-term outcomes of isolated aortic valve replacement and concomitant AVR and coronary artery bypass grafting.

de Waard GA, Jansen EK, de Mulder M, Vonk AB, Umans VA.

Neth Heart J. 2012 Mar;20(3):110-7. doi: 10.1007/s12471-011-0238-6.

19.

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses.

Yebra G, de Mulder M, Martín L, Rodríguez C, Labarga P, Viciana I, Berenguer J, Alemán MR, Pineda JA, García F, Holguín A; Cohort of the Spanish AIDS Research Network (CoRIS).

J Clin Microbiol. 2012 Feb;50(2):407-13. doi: 10.1128/JCM.05798-11. Epub 2011 Dec 7.

20.

Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population.

Yebra G, de Mulder M, Pérez-Elías MJ, Pérez-Molina JA, Galán JC, Llenas-García J, Moreno S, Holguín Á.

PLoS One. 2011;6(10):e26757. doi: 10.1371/journal.pone.0026757. Epub 2011 Oct 25.

21.

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.

de Mulder M, Yebra G, Martín L, Prieto L, Mellado MJ, Rojo P, Muñoz-Fernández MÁ, Jiménez de Ory S, Ramos JT, Holguín A; Madrid cohort of HIV-infected children.

J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305. Epub 2011 Aug 2.

PMID:
21810838
22.

Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome.

de Mulder M, Oemrawsingh RM, Stam F, Boersma E, Umans VA.

Heart. 2012 Jan;98(1):37-41. doi: 10.1136/heartjnl-2011-300163. Epub 2011 Jun 27.

PMID:
21708819
23.

Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial.

de Mulder M, Umans VA, Stam F, Cornel JH, Oemrawsingh RM, Boersma E.

Diabet Med. 2011 Oct;28(10):1168-75. doi: 10.1111/j.1464-5491.2011.03307.x.

PMID:
21480974
24.

Long-term Clinical Outcome and MIBI SPECT Parameters in Percutaneous Coronary Interventions.

de Mulder M, van der Zant FM, Knaapen P, Cornel JH, Umans VA.

Neth Heart J. 2011 Feb;19(2):68-72. Epub 2011 Feb 8.

25.

EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention.

de Mulder M, Gitt A, van Domburg R, Hochadel M, Seabra-Gomes R, Serruys PW, Silber S, Weidinger F, Wijns W, Zeymer U, Hamm C, Boersma E.

Eur Heart J. 2011 Jun;32(11):1398-408. doi: 10.1093/eurheartj/ehr034. Epub 2011 Feb 22.

PMID:
21345854
26.

Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989-2009.

Holguín A, Erazo K, Escobar G, de Mulder M, Yebra G, Martín L, Jovel LE, Castaneda L, Pérez E; Proyecto Esther.

Pediatr Infect Dis J. 2011 May;30(5):e82-7. doi: 10.1097/INF.0b013e3182117289.

PMID:
21326132
27.

Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS).

Yebra G, de Mulder M, Martín L, Pérez-Cachafeiro S, Rodríguez C, Labarga P, García F, Tural C, Jaén A, Navarro G, Holguín A; Cohort of Spanish AIDS Research Network (CoRIS).

Antiviral Res. 2011 Jan;89(1):19-25. doi: 10.1016/j.antiviral.2010.10.008. Epub 2010 Nov 9.

PMID:
21070813
28.

Diabetes mellitus and its impact on long-term outcomes after coronary artery bypass graft surgery.

Wit MA, de Mulder M, Jansen EK, Umans VA.

Acta Diabetol. 2013 Apr;50(2):123-8. doi: 10.1007/s00592-010-0223-3. Epub 2010 Sep 21.

PMID:
20857149
29.

Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy.

de Mulder M, Cornel JH, van der Ploeg T, Boersma E, Umans VA.

Am Heart J. 2010 Sep;160(3):412-9. doi: 10.1016/j.ahj.2010.06.047.

PMID:
20826247
30.

Response to 'Insulin therapy in acute coronary syndromes'.

de Mulder M, Umans VA.

Diab Vasc Dis Res. 2009 Apr;6(2):139. doi: 10.1177/1479164109336036. No abstract available.

PMID:
20368204
31.

Arterial end-to-side grafting in coronary artery bypass grafting: the Tector procedure.

de Mulder M, Broers CJ, Jansen EK, de Swart HB, Peels HO, Lieuw-A-Fa ML, Umans VA.

Neth Heart J. 2010 Jan;18(1):7-11.

32.

HIV-1 non-B subtypes: High transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability.

Yebra G, de Mulder M, del Romero J, Rodríguez C, Holguín A.

Antiviral Res. 2010 Feb;85(2):409-17. doi: 10.1016/j.antiviral.2009.11.010. Epub 2009 Dec 11.

PMID:
20004217
33.

How to implement a clinical pathway for intensive glucose regulation in acute coronary syndromes.

de Mulder M, Zwaan E, Wielinga Y, Stam F, Umans VA.

Crit Pathw Cardiol. 2009 Jun;8(2):72-8. doi: 10.1097/HPC.0b013e3181a3e577. Erratum in: Crit Pathw Cardiol. 2011 Dec;10(4):192.

PMID:
19491573
34.

Current management of hyperglycemia in acute coronary syndromes: a national Dutch survey.

de Mulder M, Oemrawsingh RM, Stam F, Boersma E, Umans VA.

Crit Pathw Cardiol. 2009 Jun;8(2):66-70; quiz 71. doi: 10.1097/HPC.0b013e3181a27fcf.

PMID:
19491572
35.

Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007).

Yebra G, Rivas P, Herrero MD, López M, de Mulder M, Puente S, Ramírez-Olivencia G, Soriano V, Holguín A.

AIDS Res Hum Retroviruses. 2009 Jan;25(1):37-44. doi: 10.1089/aid.2008.0134.

PMID:
19182919
36.

Infarct size in primary angioplasty without on-site cardiac surgical backup versus transferal to a tertiary center: a single photon emission computed tomography study.

Knaapen P, de Mulder M, van der Zant FM, Peels HO, Twisk JW, van Rossum AC, Cornel JH, Umans VA.

Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):237-43. doi: 10.1007/s00259-008-0917-8. Epub 2008 Aug 22.

PMID:
18719908
37.

Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain.

Holguín A, de Mulder M, Yebra G, López M, Soriano V.

Curr HIV Res. 2008 Jun;6(4):327-34.

PMID:
18691031

Supplemental Content

Loading ...
Support Center